KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biogen (BIIB) Net Cash Flow (2016 - 2026)

Biogen has reported Net Cash Flow over the past 18 years, most recently at $392.2 million for Q1 2026.

For Q1 2026, Net Cash Flow rose 107.51% year-over-year to $392.2 million; the TTM value through Mar 2026 reached $734.8 million, down 52.11%, while the annual FY2025 figure was $531.6 million, 61.83% down from the prior year.
Net Cash Flow for Q1 2026 was $392.2 million at Biogen, up from -$856.8 million in the prior quarter.
Over five years, Net Cash Flow peaked at $1.1 billion in Q3 2025 and troughed at -$1.3 billion in Q4 2023.
A 5-year average of $66.2 million and a median of $47.6 million in 2024 define the central range for Net Cash Flow.
On a YoY basis, Net Cash Flow climbed as much as 718.59% in 2022 and fell as far as 522.92% in 2022.
Year by year, Net Cash Flow stood at -$323.5 million in 2022, then plummeted by 297.5% to -$1.3 billion in 2023, then soared by 158.34% to $750.2 million in 2024, then crashed by 214.21% to -$856.8 million in 2025, then surged by 145.77% to $392.2 million in 2026.
Business Quant data shows Net Cash Flow for BIIB at $392.2 million in Q1 2026, -$856.8 million in Q4 2025, and $1.1 billion in Q3 2025.